Literature DB >> 8240103

Identical twins who are discordant for Leber's hereditary optic neuropathy.

D R Johns1, K H Smith, N R Miller, M E Sulewski, W B Bias.   

Abstract

OBJECTIVE: Leber's hereditary optic neuropathy is a maternally inherited form of visual loss that is associated with several mitochondrial DNA mutations. These mitochondrial DNA mutations are not the sole determinants of visual loss, as epigenetic factors may play a pathogenetic role. To clarify the role of these factors, we studied two visually discordant twins and determined their zygosity and mitochondrial genotype.
DESIGN: Case series.
SETTING: Referral center. PATIENTS: Identical twin brothers from a family with the 11778 mitochondrial DNA mutation. MAIN OUTCOME MEASURES: Visual acuity, results of testing for visual fields (measured with static and dynamic perimetry) and color vision, and results of funduscopic examination; alcohol and tobacco use, head trauma, co-existent medical illness, and occupational exposure; and results of mitochondrial DNA analysis and determination of zygosity.
RESULTS: The monozygous twin brothers have remained discordant for the development of optic neuropathy for 6 1/2 years despite harboring the identical homoplasmic 4216, 13708, and 11778 mitochondrial DNA mutations.
CONCLUSIONS: The patients are visually discordant despite being genetically identical at the nuclear and mitochondrial levels. Epigenetic factors are important determinants of visual loss in Leber's hereditary optic neuropathy in these brothers. Among those factors studied in these patients, a substantial difference was noted in regard to occupational exposure to toxic substances. Epigenetic factors that may influence the clinical expression of the mitochondrial DNA mutations associated with Leber's hereditary optic neuropathy should be systematically studied. Risk-factor intervention strategies should be formulated and implemented.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8240103     DOI: 10.1001/archopht.1993.01090110057023

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  15 in total

1.  Acquired mitochondrial impairment as a cause of optic nerve disease.

Authors:  A Sadun
Journal:  Trans Am Ophthalmol Soc       Date:  1998

2.  Leber hereditary optic neuropathy: bad habits, bad vision?

Authors:  Nancy J Newman
Journal:  Brain       Date:  2009-09       Impact factor: 13.501

Review 3.  Maternally inherited mitochondrial respiratory disorders: from pathogenetic principles to therapeutic implications.

Authors:  Martine Uittenbogaard; Anne Chiaramello
Journal:  Mol Genet Metab       Date:  2020-06-27       Impact factor: 4.797

Review 4.  Mitochondrial optic neuropathy: In vivo model of neurodegeneration and neuroprotective strategies.

Authors:  Julio C Rojas; Francisco Gonzalez-Lima
Journal:  Eye Brain       Date:  2010-03-10

Review 5.  The genetic contribution to the phenotype.

Authors:  U Wolf
Journal:  Hum Genet       Date:  1995-02       Impact factor: 4.132

6.  A twin study on age-related macular degeneration.

Authors:  S M Meyers
Journal:  Trans Am Ophthalmol Soc       Date:  1994

Review 7.  Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.

Authors:  Patrick Yu-Wai-Man; Philip G Griffiths; Patrick F Chinnery
Journal:  Prog Retin Eye Res       Date:  2010-11-26       Impact factor: 21.198

Review 8.  Leber hereditary optic neuropathy.

Authors:  P Yu-Wai-Man; D M Turnbull; P F Chinnery
Journal:  J Med Genet       Date:  2002-03       Impact factor: 6.318

9.  Pedigree analysis in Leber hereditary optic neuropathy families with a pathogenic mtDNA mutation.

Authors:  A E Harding; M G Sweeney; G G Govan; P Riordan-Eva
Journal:  Am J Hum Genet       Date:  1995-07       Impact factor: 11.025

10.  Gene-environment interactions in Leber hereditary optic neuropathy.

Authors:  Matthew Anthony Kirkman; Patrick Yu-Wai-Man; Alex Korsten; Miriam Leonhardt; Konstantin Dimitriadis; Ireneaus F De Coo; Thomas Klopstock; Patrick Francis Chinnery
Journal:  Brain       Date:  2009-06-12       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.